N. David Eansor

Companies

• Marker Therapeutics, Inc.Board member Oct 19, 2018 to now¹
• Bio-TechnePresident Mar 6, 2020 to Nov 16, 2021²
• Bio-TechneSVP - Novus Biologicals Jul 7, 2014 to Aug 21, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BTBio-Techne TECH2,117 shares⁴$153.5K at $72.53Nov 16, 2021
• MTMarker Therapeutics, Inc. MRKR9,570 shares⁵$8.8K at $0.92Mar 25, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 16, 2021Exercised options 799 shares at $125.05 of Bio-Techne⁴
• Nov 12, 2021Sold 401 shares at $506.24 of Bio-Techne⁴
• Nov 12, 2021Sold 2,535 shares at $505.49 of Bio-Techne⁴
• Nov 12, 2021Sold 8,989 shares at $504.39 of Bio-Techne⁴
• Nov 12, 2021Sold 9,043 shares at $503.61 of Bio-Techne⁴
• Nov 12, 2021Sold 4,054 shares at $502.77 of Bio-Techne⁴
• Nov 12, 2021Sold 400 shares at $505.01 of Bio-Techne⁴
• Nov 12, 2021Sold 537 shares at $504.14 of Bio-Techne⁴
• Nov 12, 2021Sold 300 shares at $502.99 of Bio-Techne⁴
• Nov 12, 2021Sold 200 shares at $504.78 of Bio-Techne⁴
• Nov 12, 2021Sold 700 shares at $504.09 of Bio-Techne⁴
• Nov 12, 2021Exercised options 27,159 shares at $125.05 of Bio-Techne⁴
• Mar 25, 2021Gift 7,142 shares of Marker Therapeutics, Inc.⁵
• Mar 25, 2021Gift 7,142 shares of Marker Therapeutics, Inc.⁵
• Mar 25, 2021Gift 14,285 shares of Marker Therapeutics, Inc.⁵
• Mar 16, 2021Bought 14,285 shares at $17.50 of Marker Therapeutics, Inc.⁵